• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER Back to Search Results
Catalog Number GSX0030A
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Cardiac Arrest (1762); Death (1802); Pericardial Effusion (3271)
Event Date 05/16/2018
Event Type  Death  
Manufacturer Narrative
(b)(4).The gore® cardioform septal occluder instructions for use includes, but is not limited to the following potential device or procedure-related adverse events associated with the use of the occluder: significant pleural or pericardial effusion requiring drainage, cardiac arrest and death.
 
Event Description
It was reported to gore a 30 mm gore® cardioform septal occluder was selected to close a patent foramen ovale.It was reported the physician tried to cross the defect prior to intracardiac echocardiogram (ice) using an sl 2 or 4 catheter, but was unsuccessful.Ice was then placed and the tunnel was able to be crossed with the sl catheter; however they were unable to access the left pulmonary vein.Access was gained to the right upper pulmonary vein, at which point the soft wire was exchanged for a stiffer 180 j wire.The gore® cardioform septal occluder delivery catheter was then advanced.The left disc was deployed and positioned on the septum.The right disc was then deployed.At this time it was reported the patient¿s pressure began to drop.The device had not been locked and was removed at this time.It was reported 1-2 60 cc syringes were used in treatment for a pericardial effusion; however, the patient went into cardiac arrest and chest compressions and medications were initiated.It was reported the patient did not survive.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® CARDIOFORM SEPTAL OCCLUDER
Type of Device
TRANSCATHETER, SEPTAL OCCLUDER
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
kathy titus
9285263030
MDR Report Key7554231
MDR Text Key109617731
Report Number2017233-2018-00309
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 05/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/30/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/18/2019
Device Catalogue NumberGSX0030A
Device Lot Number17568621
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/18/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age68 YR
Patient Weight91
-
-